Centro De Ingenieria Genetica Y Biotecnologia

Centro De Ingenieria Genetica Y Biotechnologia

Centro De Ingeniera Genetica Y Biotecnologia

Carlos Lopez Abarrategui

Gerardo Enrique Guillen Nieto

Lisset Hermida Cruz

Laura Lazo Vazquez

Aida Zulueta Morales

Beatriz De La Caridad Sierra Vazquez

Raul Rafael Espinosa Perez

Maria Guadalupe Guzman Tirado

Iris Valdes Prado

Rayner Rodriguez Diaz

Glay Chinea Santiago

Ricardo De La C Silva Rodriguez

Richardo De La C Silva Rodriguez

Iris Valdez Prado

Susana Vazquez Ramundo

Beatriz De Sierra Vazquez

María Guadalupe Guzman Tirado

Aída Zulueta Morales

The present invention is related to the obtaining of chimeric chains coding for proteins capable of inducing, in the recipient, a serotype-specific and protective humoral immune response against the infection by the Dengue virus, thus eliminating the effects of the serotype-nonespecific viral immunoenhancement that causes hemorrhagies and clinical complications described for this kind of pathology. These chimeric chains of nucleic acids are composed by the specific combination of fragments belonging to the gene of a mutated protein fromwith dehydrogenase activity and fragments that codify for a region of the envelope (E) protein from the Dengue virus which, when inserted to an expression vector, give rise to chimeric proteins with particular properties. The resultant chimeric molecules from this invention are applicable to the pharmaceutical industry for the obtaining of vaccine preparations and diagnostic means of high serotype-specificity to be used in humans.

Chimeric proteins that induce effects directed against viruses

The present invention is related to the obtaining of chimeric chains coding for proteins capable of inducing, in the recipient, a serotype-specific and protective humoral immune response against the infection by the Dengue virus, thus eliminating the effects of the serotype-nonspecific viral immunoenhancement that causes hemorrhagies and clinical complications described for this kind of pathology. These chimeric chains of nucleic acids are composed by the specific combination of fragments belonging to the gene of a mutated protein fromwith dehydrogenase activity and fragments that codify for a region of the envelope (E) protein from the Dengue virus which, when inserted to an expression vector, give rise to chimeric proteins with particular properties. The resultant chimeric molecules from this invention are applicable to the pharmaceutical industry for the obtaining of vaccine preparations and diagnostic means of high serotype-specificity to be used in humans.

Growing community of inventors

Ciudad de la Habana, Cuba

Carlos Lopez Abarrategui